ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDWARD ESPINOSA MD

Internal Medicine

1,958

$95.5K

158
130 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

SHELLEY DAVIS M.D.

Internal Medicine

1,347

$133K

206
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $56

JULIET ASHER MD

Internal Medicine

1,454

$70.8K

88
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

OLIVIA BUSH MD

Internal Medicine

1,441

$44.7K

269
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$31
Average prescription price

Avg: $56

MEHUL TEJANI M.D., M.P.H.

Internal Medicine

3,849

$763K

369
170 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $56

INDIRA DEVU MD

Internal Medicine

4,662

$226K

216
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

YOHANNES BELACHEW M.D

Internal Medicine

1,044

$30.2K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$29
Average prescription price

Avg: $56

AAKASH AMIN M.D.

Internal Medicine

524

$118K

79
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 26%

$224
Average prescription price

Avg: $56

ROBERT SILBERMAN MD

Internal Medicine

1,424

$49K

186
70 are 65+

36%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

JASON NESMITH M.D.

Internal Medicine

1,333

$40.6K

193
132 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$30
Average prescription price

Avg: $56

CHARLES BURKE M. D.

Internal Medicine

5,830

$277K

326
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

LAURIE LAMMERT MD

Internal Medicine

1,677

$84.5K

182
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

JAMES WEST M.D.

Internal Medicine

3,752

$412K

271
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 26%

$110
Average prescription price

Avg: $56

SUSMITA PARASHAR MD

Internal Medicine

436

$26.1K

67
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

MICHAEL SAENGER M.D.

Internal Medicine

1,782

$104K

202
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $56

OLURANTI ALADESANMI MD

Internal Medicine

2,153

$104K

350
299 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

ANITHA NAGAPPAN M.D.

Internal Medicine

937

$31.2K

217
182 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$33
Average prescription price

Avg: $56

MARY KIM M.D.

Internal Medicine

1,266

$67.3K

75
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

ROBERT HUMMER M.D.

Internal Medicine

451

$19K

154
108 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

MAI-AHN PHAM MD

Internal Medicine

2,435

$75.3K

196
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$31
Average prescription price

Avg: $56

ELIAZABETH SMITH M.D.

Internal Medicine

3,517

$184K

210
154 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

ADAM HENSLEY M.D.

Internal Medicine

1,189

$40.6K

165
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

WILLIAM MCGARITY M.D.

Internal Medicine

5,323

$335K

230
196 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $56

BHAGYA LAKSHMI PAPUDESU M.D.

Internal Medicine

873

$33.8K

118
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

SANDRA FRYHOFER MD

Internal Medicine

770

$61.1K

53
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 26%

$79
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank